These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
572 related articles for article (PubMed ID: 19136510)
21. MRI evaluation of inflammatory activity in Crohn's disease. Sempere GA; Martinez Sanjuan V; Medina Chulia E; Benages A; Tome Toyosato A; Canelles P; Bulto A; Quiles F; Puchades I; Cuquerella J; Celma J; Orti E AJR Am J Roentgenol; 2005 Jun; 184(6):1829-35. PubMed ID: 15908538 [TBL] [Abstract][Full Text] [Related]
22. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease. Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192 [TBL] [Abstract][Full Text] [Related]
23. Crohn disease of the small bowel proximal to the terminal ileum: detection by MR-enteroclysis. Ochsenkühn T; Herrmann K; Schoenberg SO; Reiser MF; Göke B; Sackmann M Scand J Gastroenterol; 2004 Oct; 39(10):953-60. PubMed ID: 15513334 [TBL] [Abstract][Full Text] [Related]
24. Magnetic resonance colonography for the evaluation of colonic inflammatory bowel disease: correlation with conventional colonoscopy. Ergen FB; Akata D; Hayran M; Harmanci O; Arslan S; Basaran C; Hussain HK J Comput Assist Tomogr; 2008; 32(6):848-54. PubMed ID: 19204442 [TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance enterography in Crohn's disease: a comparison with the findings at surgery. Fallis SA; Murphy P; Sinha R; Hawker P; Gladman L; Busby K; Sanders S Colorectal Dis; 2013; 15(10):1273-80. PubMed ID: 23869486 [TBL] [Abstract][Full Text] [Related]
26. [Assessment of inflammatory activity in Crohn disease with hydro-MRI]. Schunk K; Kern A; Heussel CP; Kalden P; Mayer I; Orth T; Wanitschke R Rofo; 2000 Feb; 172(2):153-60. PubMed ID: 10723489 [TBL] [Abstract][Full Text] [Related]
27. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn's disease. Florie J; Wasser MN; Arts-Cieslik K; Akkerman EM; Siersema PD; Stoker J AJR Am J Roentgenol; 2006 May; 186(5):1384-92. PubMed ID: 16632735 [TBL] [Abstract][Full Text] [Related]
28. Biochemical markers and MR imaging findings as predictors of crohn disease activity in patients scanned by contrast-enhanced MR enterography. Quaia E; Cabibbo B; Sozzi M; Gennari AG; Pontello M; Degrassi F; Cova MA Acad Radiol; 2014 Oct; 21(10):1225-32. PubMed ID: 24998692 [TBL] [Abstract][Full Text] [Related]
29. Assessment of Crohn's disease activity in the small bowel with MR-enteroclysis: clinico-radiological correlations. Malagò R; Manfredi R; Benini L; D'Alpaos G; Mucelli RP Abdom Imaging; 2008; 33(6):669-75. PubMed ID: 18228087 [TBL] [Abstract][Full Text] [Related]
30. Contrast-enhanced MR enterography as a stand-alone tool to evaluate Crohn's disease in a paediatric population. Spieler B; Hindman N; Levy J; Zabrieski K; Sahlein D; Seuss C; Kim S Clin Radiol; 2013 Oct; 68(10):1024-30. PubMed ID: 23796211 [TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance enterocolonography in detecting erosion and redness in intestinal mucosa of patients with Crohn's disease. Sato H; Tamura C; Narimatsu K; Shimizu M; Takajyo T; Yamashita M; Inoue Y; Ozaki H; Furuhashi H; Maruta K; Yasutake Y; Yoshikawa K; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Shinmoto H; Hokari R J Gastroenterol Hepatol; 2015 Apr; 30(4):667-73. PubMed ID: 25387770 [TBL] [Abstract][Full Text] [Related]
33. Impact of disease location on fecal calprotectin levels in Crohn's disease. Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819 [TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance enteroclysis in the diagnosis of small-intestinal Crohn's disease: diagnostic accuracy and inter- and intra-observer agreement. Negaard A; Sandvik L; Mulahasanovic A; Berstad AE; Klöw NE Acta Radiol; 2006 Dec; 47(10):1008-16. PubMed ID: 17135001 [TBL] [Abstract][Full Text] [Related]
35. Active Crohn's disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging. Oto A; Kayhan A; Williams JT; Fan X; Yun L; Arkani S; Rubin DT J Magn Reson Imaging; 2011 Mar; 33(3):615-24. PubMed ID: 21563245 [TBL] [Abstract][Full Text] [Related]
36. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969 [TBL] [Abstract][Full Text] [Related]
37. Endoscopy and magnetic resonance imaging in patients with Crohn's disease: a retrospective single-centre comparative study. Dinter DJ; Chakraborty A; Brade J; Back W; Neff KW; Singer MV; Böcker U Scand J Gastroenterol; 2008; 43(2):207-16. PubMed ID: 17918002 [TBL] [Abstract][Full Text] [Related]
39. [Importance of colonoscopy combined with biopsy in the diagnosis of colonic Crohn's disease]. Zheng JJ; Chu XQ; Shi XH; Wang YM; Jia LM; Zhou CL; Wang FM Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(28):1970-3. PubMed ID: 16313774 [TBL] [Abstract][Full Text] [Related]